NCCN teams up with ASCO to provide guidelines for use of new cancer-fighting drugs

The Montgomery County-based-based National Comprehensive Cancer Network and the American Society of Clinical Oncology have published new guidelines to help clinicians manage side effects related to immune checkpoint inhibitors used in immunotherapy treatments. Immunotherapy, which is revolutionizing the way some cancers are being treated, aims at improving the way a patient's own immune system identifies and attacks invading tumors. Immune checkpoint inhibitors are drugs – often made of antibodies…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news